[Effects of intravenously and intraperitoneally applied solutions of disodium-ethylendiamintetraacetic acid (EDTA-med) on blood sugar and biometals in pancreas, liver and kidney].
D000818:Animals; D001653:Bile Ducts, Intrahepatic / Q000378:metabolism; D001786:Blood Glucose / Q000378:metabolism*; D002118:Calcium / Q000378:metabolism*; D004492:Edetic Acid / Q000494:pharmacology*; D005260:Female; D006651:Histocytochemistry; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007668:Kidney / Q000378:metabolism*; D007684:Kidney Tubules / Q000378:metabolism; D008099:Liver / Q000378:metabolism*; D008297:Male; D012157:Mononuclear Phagocyte System / Q000378:metabolism; D010179:Pancreas / Q000378:metabolism*; D051381:Rats; D014131:Trace Elements / Q000378:metabolism*
D001786:Blood Glucose; D014131:Trace Elements; D004492:Edetic Acid; D002118:Calcium
Zur Wirking intravenös und intraperitoneal verabfolgter Lösungen des Dinatriumsalzes der Athylendiamintetraessigsäure (EDTA-med) auf Blutzucker und Biometalle in Pankreas, Leber und Niere.